TMOD-17. A NOVEL ADENOVIRAL-PERMISSIVE, IMMUNOCOMPETENT HAMSTER MODEL TO EVALUATE ONCOLYTIC ADENOVIRAL THERAPY FOR GLIOBLASTOMA

Published on Nov 5, 2018in Neuro-oncology10.247
· DOI :10.1093/NEUONC/NOY148.1129
Lynette Phillips4
Estimated H-index: 4
(University of Texas MD Anderson Cancer Center),
Shoudong Li1
Estimated H-index: 1
(University of Texas MD Anderson Cancer Center)
+ 6 AuthorsFrederick Lang10
Estimated H-index: 10
(University of Texas MD Anderson Cancer Center)
Source
Abstract
References0
Newest
Cited By0
Newest